From Medscape Rheumatology

Coverage from the

British Society for Rheumatology (BSR) 2023 Annual Meeting

April 24 - 26, 2023; Manchester, UK, and Virtual

April 24 - 26, 2023 Manchester, UK, and Virtual
  • BSR 2023 Meta-Analysis Probes Cancer Risk Concern for JAK Inhibitors Although no increased cancer risk was seen vs methotrexate or placebo, Janus kinase inhibitors were associated with a higher cancer risk than were tumor necrosis factor inhibitors in a meta-analysis.

Conference News

Medscape Rheumatology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Popular News From BSR 2022

Previous Coverage